Cat. No.: DIA-0243174
Product Information | |
---|---|
CAS No. | 2259884-03-0 |
Synonyms | IBI-362; LY-3305677; OXM-3 |
Formula | C210H322N46O67 |
Molecular Weight | 4563.06 |
Target | GCGR, GLP Receptor |
Product Description | Mazdutide (IBI-362; LY-3305677) is a long-acting synthetic oxyntomodulin analog. Mazdutide is also a co-agonist of glucagon-like peptide (GLP-1R) and?glucagon receptor?(GCGR). Mazdutide binds human and mouse?GCGR?(Ki: 17.7 nM and 15.9 nM, respectively) and GLP-1R (Ki: 28.6 nM and 25.1 nM, respectively) and stimulates?insulin?secretion from mouse islets (EC50: 5.2 nM). Mazdutide is used in studies of obesity and type 2 diabetes (T2D). |
Format & Storage | |
---|---|
Format | Solid |
Color | White to off-white |
Purity | 99.74% |
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
Solubility Overview | Soluble in water |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.